The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 09, 2022

Filed:

Aug. 22, 2018
Applicant:

Northeastern University, Boston, MA (US);

Inventors:

Jonathan R. Soucy, Boston, MA (US);

Ehsan Shirzaei Sani, Boston, MA (US);

Abigail N. Koppes, Charlestown, MA (US);

Ryan A. Koppes, Charlestown, MA (US);

Nasim Annabi, Cambridge, MA (US);

Assignee:

Northeastern University, Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/52 (2006.01); A61L 27/38 (2006.01); A61L 27/26 (2006.01); A61L 27/22 (2006.01); A61B 17/11 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61L 27/52 (2013.01); A61B 17/1128 (2013.01); A61L 27/222 (2013.01); A61L 27/227 (2013.01); A61L 27/26 (2013.01); A61L 27/383 (2013.01); A61L 27/3878 (2013.01); A61B 17/00491 (2013.01); A61B 2017/1132 (2013.01); A61L 2430/32 (2013.01);
Abstract

Neurosupportive materials that possess strong tissue adhesion were synthesized by photocrosslinking two polymers, gelatin methacryloyl (GelMA) and methacryloyl-substituted tropoelastin (MeTro). The engineered materials exhibited tunable mechanical properties by varying the GelMA/MeTro ratio. In addition, GelMA/MeTro hydrogels exhibited 15-fold higher adhesive strength to nerve tissue ex vivo compared to traditionally used fibrin-based materials. Furthermore, the composites were shown to support Schwann cell (SC) viability and proliferation, as well as neurite extension and glial cell participation in vitro, which are essential cellular components for nerve regeneration. Finally, subcutaneously implanted GelMA/MeTro hydrogels exhibited slower degradation in vivo compared with pure GelMA, indicating its potential to support the growth of slowly regenerating nerves. Thus, GelMA/MeTro composites may be used as clinically relevant biomaterials to regenerate nerves and reduce the need for microsurgical suturing during nerve reconstruction.


Find Patent Forward Citations

Loading…